Pharmacy stocks run low as Turkey's drug price policy hits supplies - (The Economic Times via NewsPoints Desk)

  • This year, following the sharp depreciation of the Turkish lira, medicine shortages in Turkey have been even more severe than previous years, as reported The Economic Times.

  • Turkish Pharmacists' Association head Erdogan Colak said 150 types of medicine were unavailable in the market in January.

  • The government, which is trying to cap spending, is expected to raise the drug price rate by 15 percent, while pharmaceutical companies are asking for a minimum of 35 percent.

  • According to Nezih Barut, head of the Pharmaceutical Manufacturers Association of Turkey, drugmakers could not operate properly if the government proposal is approved.

  • "In such a situation, drugs would be nowhere to be found because as drug companies, we are at a point where we are having a lot of difficulty even with raw materials supplies," he said.

  • Meanwhile, Health Minister Fahrettin Koca, who recently gave authorisation for 41 drugs to be sold at prices higher than those set by the fixed exchange rate, said cancer, influenza medicines and antibiotics were among medicines that would be affected by the price liberalisation.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.